- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
- 10-Q Quarterly report
- 3.1 Amended and Restated Articles of Incorporation
- 10.1 Exclusive License Agreement Between Targeted Genetics and Alkermes, Inc.
- 10.2 Eighth Lease Amendment
- 10.3 Seventh Amendment to Olive Way Building Lease
- 10.4 Lease Termination Agreement
- 10.5 Targeted Genetics Corporation Stock Incentive Plan
- 31.1 Certification Pursuant to Rules 13A-15(E) and 15D-15(E)
- 31.2 Certification Pursuant to Rules 13A-15(E) and 15D-15(E)
- 32.1 Section 906 CEO Certification
- 32.2 Section 906 CFO Certification
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Targeted Genetics Corporation (the “Company”) for the period ended June 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, B.G. Susan Robinson, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: August 12, 2009 | /s/ B.G. SUSAN ROBINSON B.G. Susan Robinson President and Chief Executive Officer |